These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 2322126)

  • 1. Natural killer cell activity in patients with dementia of the Alzheimer type.
    Araga S; Kagimoto H; Funamoto K; Adachi A; Inoue K; Takahashi K
    Arch Neurol; 1990 Apr; 47(4):380-1. PubMed ID: 2322126
    [No Abstract]   [Full Text] [Related]  

  • 2. Decreased immunosuppressive effect of cortisol on natural killer cytotoxic activity in senile dementia of the Alzheimer type.
    Solerte SB; Cerutti N; Severgnini S; Rondanelli M; Ferrari E; Fioravanti M
    Dement Geriatr Cogn Disord; 1998; 9(3):149-56. PubMed ID: 9622003
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dehydroepiandrosterone-sulfate (DHEA-S) restores the release of IGF-I from natural killer (NK) immune in old patients with dementia of Alzheimer's type (DAT).
    Solerte SB; Gornati R; Cravello L; Albertelli N; Oberti S; Perotta D; Rossi G; Cuzzoni G; Ferrari E; Fioravanti M
    J Endocrinol Invest; 1999; 22(10 Suppl):32-4. PubMed ID: 10727032
    [No Abstract]   [Full Text] [Related]  

  • 4. Dehydroepiandrosterone sulfate decreases the interleukin-2-mediated overactivity of the natural killer cell compartment in senile dementia of the Alzheimer type.
    Solerte SB; Fioravanti M; Schifino N; Cuzzoni G; Fontana I; Vignati G; Govoni S; Ferrari E
    Dement Geriatr Cogn Disord; 1999; 10(1):21-7. PubMed ID: 9844034
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Excitatory pattern of gamma-interferon on natural killer cell activity in senile dementia of the Alzheimer type.
    Solerte SB; Fioravanti M; Severgnini S; Pezza N; Locatelli M; Cerutti N; Terenzi F; Ferrari E
    Dement Geriatr Cogn Disord; 1997; 8(5):308-13. PubMed ID: 9298632
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of non-steroidal anti-inflammatory drugs on natural killer cell activity in patients with dementia.
    Aizen E; Kagan G; Assy B; Iobel R; Bershadsky Y; Gilhar A
    Isr Med Assoc J; 2005 Feb; 7(2):78-81. PubMed ID: 15729955
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Overproduction of IFN-gamma and TNF-alpha from natural killer (NK) cells is associated with abnormal NK reactivity and cognitive derangement in Alzheimer's disease.
    Solerte SB; Cravello L; Ferrari E; Fioravanti M
    Ann N Y Acad Sci; 2000; 917():331-40. PubMed ID: 11268360
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Regional cerebral blood flow and brain atrophy in senile dementia of Alzheimer type compared to multi-infarct dementia and aged controls].
    Okada K; Kobayashi S; Yamaguchi S; Kitani M; Tsunematsu T
    Rinsho Shinkeigaku; 1987 May; 27(5):545-51. PubMed ID: 3621750
    [No Abstract]   [Full Text] [Related]  

  • 9. [Natural killer cell activity, activity of lymphokine activated killer cells (LAK activity), killer helper factor (KHF)].
    Watabe H; Abo T
    Nihon Rinsho; 1999 Nov; 57 Suppl():666-9. PubMed ID: 10635943
    [No Abstract]   [Full Text] [Related]  

  • 10. NK Cells are Activated in Amnestic Mild Cognitive Impairment but not in Mild Alzheimer's Disease Patients.
    Le Page A; Bourgade K; Lamoureux J; Frost E; Pawelec G; Larbi A; Witkowski JM; Dupuis G; Fülöp T
    J Alzheimers Dis; 2015; 46(1):93-107. PubMed ID: 25720398
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of coexistent Alzheimer pathology on the natural history of Parkinson's disease.
    Jellinger KA; Seppi K; Wenning GK; Poewe W
    J Neural Transm (Vienna); 2002 Mar; 109(3):329-39. PubMed ID: 11956955
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association between altered systemic inflammatory interleukin-1beta and natural killer cell activity and subsequently agitation in patients with Alzheimer disease.
    Higuchi M; Hatta K; Honma T; Hitomi YH; Kambayashi Y; Hibino Y; Matsuzaki I; Sasahara S; Nakamura H
    Int J Geriatr Psychiatry; 2010 Jun; 25(6):604-11. PubMed ID: 19728317
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [System of natural killer lymphocytes in Alzheimer's type dementias].
    Vasil'eva LF; Kushner SG; Selezneva ND
    Zh Nevrol Psikhiatr Im S S Korsakova; 1998; 98(10):41-4. PubMed ID: 9819888
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The electroencephalogram in Alzheimer-type dementia. A sequential study correlating the electroencephalogram with psychometric and quantitative pathologic data.
    Rae-Grant A; Blume W; Lau C; Hachinski VC; Fisman M; Merskey H
    Arch Neurol; 1987 Jan; 44(1):50-4. PubMed ID: 3800722
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Late-Onset Alzheimer Disease.
    Pierce AL; Bullain SS; Kawas CH
    Neurol Clin; 2017 May; 35(2):283-293. PubMed ID: 28410660
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recent advances in dementia research in Japan: Alzheimer-type dementia.
    Kosaka K; Iseki E; Arai H
    Psychiatry Clin Neurosci; 1999 Feb; 53(1):1-10. PubMed ID: 10201277
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dementia of the Alzheimer type.
    Terry RD; Davies P
    Annu Rev Neurosci; 1980; 3():77-95. PubMed ID: 6251745
    [No Abstract]   [Full Text] [Related]  

  • 18. The effects of age on rate of progression of Alzheimer disease and dementia with associated cerebrovascular disease.
    Mungas D; Reed BR; Ellis WG; Jagust WJ
    Arch Neurol; 2001 Aug; 58(8):1243-7. PubMed ID: 11493164
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acute effect of qi-training on natural killer cell subsets and cytotoxic activity.
    Lee M; Kang CW; Ryu H
    Int J Neurosci; 2005 Feb; 115(2):285-97. PubMed ID: 15764007
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Genetic mechanisms for the regulation of natural killer cell activity].
    Shparyk IaV; Shloma DV
    Tsitol Genet; 1990; 24(6):57-63. PubMed ID: 2098956
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.